Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

NCT05899543 ·Status: NOT_YET_RECRUITING

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

NCT05557695 ·Status: RECRUITING

An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia

NCT01395615 ·Status: COMPLETED

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

NCT01699217 ·Status: COMPLETED

National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent

NCT02903277 ·Status: UNKNOWN

Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01185886 ·Status: UNKNOWN

Study on the Diagnosis and Management of CLL in Italy by GIMEMA

NCT04867915 ·Status: RECRUITING

Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia

NCT06814444 ·Status: RECRUITING

Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Leukemia

NCT00917540 ·Status: UNKNOWN

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice

NCT03425591 ·Status: COMPLETED

A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG

NCT06792994 ·Status: RECRUITING

Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib

NCT01761890 ·Status: UNKNOWN

Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia

NCT05971251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities

NCT02915224 ·Status: COMPLETED

Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT01274351 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Acute Myeloblastic Leukemia in Younger Patients

NCT00390715 ·Status: COMPLETED

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

NCT02582879 ·Status: COMPLETED

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

NCT07189117 ·Status: RECRUITING

Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

NCT03367299 ·Status: COMPLETED ·Phase: PHASE2

Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia

NCT00281918 ·Status: COMPLETED ·Phase: PHASE3

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

NCT03075969 ·Status: UNKNOWN

The Value of Follow-Up After Childhood Acute Lymphoblastic Leukaemia in Denmark - Family Perspectives

NCT03985215 ·Status: WITHDRAWN

Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL

NCT04342117 ·Status: TERMINATED

A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies

NCT05944978 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Natural History Study of Patients With Chronic Myelogenous Leukemia

NCT00429910 ·Status: COMPLETED